Eliciting societal preferences of reimbursement decision criteria for anti cancer drugs in South Korea

References

• Ngorsuraches S, Meng W, Kim BY, et al. Drug reimbursement decision-making in Thailand, China, and South Korea. Value Health. 2012;15:S120–S125.
   PubMed Web of Science ®Google Scholar
• Park SE, Lim SH, Choi HW, et al. Evaluation on the first 2 years of the positive list system in South Korea. Health Policy. 2012;104:32–39.
   PubMed Web of Science ®Google Scholar
• Nord E, Daniels N, Kamlet M, QALYs: some challenges. Value Health. 2009;12(Suppl 1):S10–S15. Epub 2009/03/11.
   PubMed Web of Science ®Google Scholar
• Schlander M. The use of cost-effectiveness by the National Institute for Health and Clinical Excellence (NICE): no(t yet an) exemplar of a deliberative process. J Med Ethics. 2008;34:534–539. Epub 2008/07/02.
   PubMed Web of Science ®Google Scholar
• Baltussen R, Leidl R, Ament A. Real world designs in economic evaluation. Bridging the gap between clinical research and policy-making. Pharmacoeconomics. 1999;16:449–458. Epub 2000/02/08.
   PubMed Web of Science ®Google Scholar
• Thokala P, Devlin N, Marsh K, et al. Multiple criteria decision analysis for health care decision making—an Introduction: report 1 of the ISPOR MCDA emerging good practices task force. Value Health. 2016;19:1–13.
   PubMed Web of Science ®Google Scholar
• Youngkong S, Teerawattananon Y, Tantivess S, et al. Multi-criteria decision analysis for setting priorities on HIV/AIDS interventions in Thailand. Health Res Policy Syst. 2012;10.
   PubMed Web of Science ®Google Scholar
• Drummond M, Evans B, LeLorier J, et al. Evidence and values: requirements for public reimbursement of drugs for rare diseases–a case study in oncology. Can J Clin Pharmacol. 2009;16:e273-e284.
   PubMedGoogle Scholar
• Greenberg D, Earle C, Fang C-H, et al. When is cancer care cost-effective? A systematic overview of cost–utility analyses in oncology. J Natl Cancer Inst. 2010;102:82–88.
   PubMed Web of Science ®Google Scholar
• Mühlbacher AC, Juhnke C. Patient preferences versus physicians’ judgement: does it make a difference in healthcare decision making? Appl Health Econ Health Policy. 2013;11:163–180.
   PubMedGoogle Scholar
• Saaty TL. Decision making—the analytic hierarchy and network processes (AHP/ANP). J Syst Sci Syst Eng. 2004;13:1–35.
   Google Scholar
• Porter ME, Teisberg EO. Redefining health care: creating value-based competition on results. Harv Bus Rev. 2006.
   Google Scholar
• Bae E-Y, Hong J-M, Kwon H-Y, et al. Eight-year experience of using HTA in drug reimbursement: South Korea. Health Policy. 2016;120:612–620.
   PubMed Web of Science ®Google Scholar
• Cromwell I, Peacock SJ, Mitton C. ‘Real-world’ health care priority setting using explicit decision criteria: a systematic review of the literature. BMC Health Serv Res. 2015;15:164.
   PubMed Web of Science ®Google Scholar
• Wahlster P, Goetghebeur M, Kriza C, et al. Balancing costs and benefits at different stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA). BMC Health Serv Res. 2015;15:262.
   PubMed Web of Science ®Google Scholar
• Tanios N, Wagner M, Tony M, et al.; International Task Force on Decision C. Which criteria are considered in healthcare decisions? Insights from an international survey of policy and clinical decision makers. Int J Technol Assess Health Care. 2013;29:456–465.
   PubMed Web of Science ®Google Scholar
• Golan O, Hansen P, Kaplan G, et al. Health technology prioritization: which criteria for prioritizing new technologies and what are their relative weights? Health Policy. 2011;102:126–135.
   PubMed Web of Science ®Google Scholar
• Linley WG, Hughes DA. Societal views on NICE, cancer drugs fund and value-based pricing criteria for prioritising medicines: a cross-sectional survey of 4118 adults in Great Britain. Health Econ. 2013;22:948–964.
   PubMed Web of Science ®Google Scholar
• Sabik LM, Lie RK. Priority setting in health care: lessons from the experiences of eight countries. Int J Equity Health. 2008;7:1.
   PubMed Web of Science ®Google Scholar
• Sussex J, Towse A, Devlin N. Operationalizing value-based pricing of medicines: a taxonomy of approaches. Pharmacoeconomics. 2013;31:1–10.
   PubMed Web of Science ®Google Scholar
• Baeten SA, Baltussen RM, Uyl-De Groot CA, et al. Incorporating equity-efficiency interactions in cost-effectiveness analysis-three approaches applied to breast cancer control. Value Health. 2010;13:573–579.
   PubMed Web of Science ®Google Scholar
• Baltussen R, Youngkong S, Paolucci F, et al. Multi-criteria decision analysis to prioritize health interventions: capitalizing on first experiences. Health Policy. 2010;96:262–264.
   PubMed Web of Science ®Google Scholar
• Mirelman A, Mentzakis E, Kinter E, et al. Decision-making criteria among national policymakers in five countries: a discrete choice experiment eliciting relative preferences for equity and efficiency. Value Health. 2012;15:534–539. Epub 2012/05/16.
   PubMed Web of Science ®Google Scholar
• Sussex J, Rollet P, Garau M, et al. A pilot study of multicriteria decision analysis for valuing orphan medicines. Value Health. 2013;16:1163–1169.
   PubMed Web of Science ®Google Scholar
• Ferner RE, Hughes DA, Aronson JK. NICE and new: appraising innovation. BMJ. 2010;340:b5493.
   PubMed Web of Science ®Google Scholar
• Henshall C, Schuller T, Forum HTP. Health technology assessment, value-based decision making, and innovation. Int J Technol Assess Health Care. 2013;29:353–359.
   PubMed Web of Science ®Google Scholar
• Belton V, Stewart T. Multiple criteria decision analysis: an integrated approach. Boston: Kluwer Academic Publishers. Springer Science & Business Media; 2002.
   Google Scholar
• Goetghebeur MM, Wagner M, Khoury H, et al. Combining multicriteria decision analysis, ethics and health technology assessment: applying the EVIDEM decision-making framework to growth hormone for Turner syndrome patients. Cost Eff Resour Alloc. 2010;8:4.
   PubMedGoogle Scholar
• Defechereux T, Paolucci F, Mirelman A, et al. Health care priority setting in Norway a multicriteria decision analysis. BMC Health Serv Res. 2012;12:39.
   PubMed Web of Science ®Google Scholar
• Jehu-Appiah C, Baltussen R, Acquah C, et al. Balancing equity and efficiency in health priorities in Ghana: the use of multicriteria decision analysis. Value Health. 2008;11:1081–1087.
   PubMed Web of Science ®Google Scholar
• Marsh K, Lanitis T, Neasham D, et al. Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature. Pharmacoeconomics. 2014;32:345–365.
   PubMed Web of Science ®Google Scholar
• Hummel MJ, Volz F, van Manen JG, et al. Using the analytic hierarchy process to elicit patient preferences: prioritizing multiple outcome measures of antidepressant drug treatment. Patient. 2012;5:225–237. Epub 2012/10/27.
   PubMedGoogle Scholar
• de bekker-Grob EW, Ryan M, Gerard K. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012;21:145–172.
   PubMed Web of Science ®Google Scholar
• Marsh K, IJzerman M, Thokala P, et al. Multiple criteria decision analysis for health care decision making—emerging good practices: report 2 of the ISPOR MCDA emerging good practices task force. Value Health. 2016;19:125–137.
   PubMed Web of Science ®Google Scholar
• Hossain MF, Adnan ZH, Hasin M. Improvement in weighting assignment process in analytic hierarchy process by introducing suggestion matrix and likert scale. Int J Sup Chain Mgt. 2014;3.
   Google Scholar
• Aupetit B, Genest C. On some useful properties of the Perron eigenvalue of a positive reciprocal matrix in the context of the analytic hierarchy process. Eur J Oper Res. 1993;70:263–268.
   Web of Science ®Google Scholar
• Saaty TL. Decision-making with the AHP: why is the principal eigenvector necessary. Eur J Oper Res. 2003;145:85–91.
   Web of Science ®Google Scholar
• Srdjevic B. Combining different prioritization methods in the analytic hierarchy process synthesis. Comput Oper Res. 2005;32:1897–1919.
   Web of Science ®Google Scholar
• Saaty TL. A scaling method for priorities in hierarchical structures. J Math Psychol. 1977;15:234–281.
   Web of Science ®Google Scholar
• Schmidt K, Aumann I, Hollander I, et al. Applying the analytic hierarchy process in healthcare research: a systematic literature review and evaluation of reporting. BMC Med Inform Decis Mak. 2015;15:112.
   PubMed Web of Science ®Google Scholar
• Kelley K, Clark B, Brown V, et al. Good practice in the conduct and reporting of survey research. Int J Qual Health Care. 2003;15:261–266.
   PubMed Web of Science ®Google Scholar
• Semaan S, Lauby J, Liebman J. Street and network sampling in evaluation studies of HIV risk-reduction interventions. AIDS Rev. 2002;4:213–223. Epub 2003/01/31.
   PubMedGoogle Scholar
• Aday LA, Cornelius LJ. Designing and conducting health surveys: a comprehensive guide. San Francisco: John Wiley & Sons; 2006;128–129.
   Google Scholar
• Julious SA. Sample sizes for clinical trials. Boca Raton, FL: CRC Press; 2009.
   Google Scholar
• Baji P, Garcia-Goni M, Gulacsi L, et al. Comparative analysis of decision maker preferences for equity/efficiency attributes in reimbursement decisions in three European countries. Eur J Health Econ. 2016;17:791–799.
   PubMed Web of Science ®Google Scholar
• Sussex J, Rollet P, Garau M, et al. Multi-criteria decision analysis to value orphan medicines. OHE Research Paper. 2013;13.
   Google Scholar
• Insinga RP, Fryback DG. Understanding differences between self-ratings and population ratings for health in the EuroQOL. Qual Life Res. 2003;12:611–619.
   PubMed Web of Science ®Google Scholar
• Mott DJ, Najafzadeh M. Whose preferences should be elicited for use in health-care decision-making? A case study using anticoagulant therapy. Expert Rev Pharmacoecon Outcomes Res. 2016;16:33–39.
   PubMed Web of Science ®Google Scholar
• Goetghebeur MM, Wagner M, Khoury H, et al. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal. Med Decis Making. 2012;32:376–388.
   PubMed Web of Science ®Google Scholar
• Tony M, Wagner M, Khoury H, et al. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada. BMC Health Serv Res. 2011;11:329.
   PubMed Web of Science ®Google Scholar
• Danner M, Hummel JM, Volz F, et al. Integrating patients’ views into health technology assessment: Analytic Hierarchy Process (AHP) as a method to elicit patient preferences. Int J Technol Assess Health Care. 2011;27:369–375.
   PubMed Web of Science ®Google Scholar
• Hummel JM, Boomkamp IS, Steuten LM, et al. Predicting the health economic performance of new non-fusion surgery in adolescent idiopathic scoliosis. J Orthop Res. 2012;30:1453–1458.
   PubMed Web of Science ®Google Scholar
• Mentzakis E, Paolucci F, Rubicko G. Priority setting in the Austrian healthcare system: results from a discrete choice experiment and implications for mental health. J Ment Health Policy Econ. 2014;17:61–73.
   PubMed Web of Science ®Google Scholar
• Wahlster P, Goetghebeur M, Schaller S, et al. Exploring the perspectives and preferences for HTA across German healthcare stakeholders using a multi-criteria assessment of a pulmonary heart sensor as a case study. Health Res Policy Syst. 2015;13:24.
   PubMed Web of Science ®Google Scholar